As previously reported, BofA downgraded Leslie’s (LESL) to Underperform from Buy with a price target of $1.40, down from $2.65, citing share loss weighing on top line growth, “disappointing” FY25 EBITDA guidance and muted free cash flow generation limiting the company’s ability to pay down debt. The firm lowered its FY25 and FY26 adjusted EBITDA estimates by 18% and 23%, respectively, to reflect weaker sales growth and lower margins.
Protect Your Portfolio Against Market Uncertainty
- Discover companies with rock-solid fundamentals in TipRanks' Smart Value Newsletter.
- Receive undervalued stocks, resilient to market uncertainty, delivered straight to your inbox.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on LESL: